Alert List

StayAlert! is MCN Healthcare's email notification system for regulatory changes. Enjoy this free sample content.

Like what you see? Sign up for a

Free 30 Day Trial

FDA updates on angiotensin II receptor blocker (ARB) recalls including valsartan, losartan and irbesartan
Mar 21 2019
Strategies to Prevent Patient Falls
Mar 20 2019
FDA Issues Warning Letters to Two Breast Implant Manufacturers
Mar 20 2019
Recall of Mylan Institutional LLC Levoleucovorin Injection
Mar 19 2019
Class I Recall of Transseptal Needle by Cook Medical, Inc.
Mar 19 2019
Hospira, Inc. Issues a Voluntary Nationwide Recall of 8.4% Sodium Bicarbonate Injection, USP
Mar 18 2019
Recall of Losartan Potassium Tablets by Legacy Pharmaceutical Packaging
Mar 18 2019
OIG March 2019 Work Plan
Mar 18 2019
FDA Warns of Increased Mortality with Paclitaxel-Coated Balloons and Paclitaxel-Eluting Stents
Mar 15 2019
Unintended Retention of Foreign Objects Remains Persistent Safety Issue
Mar 15 2019
TJC 2018 Sentinel Event Statistics
Mar 14 2019
CMS Publishes Specialized Infection Prevention and Control Training for Nursing Home Staff
Mar 13 2019
TJC Clarifies Applicability of Requirements for NPSG.15.01.01
Mar 12 2019
Safe Use of Surgical Staplers and Staples
Mar 11 2019
American Health Packaging Issues Recall of Valsartan Tablets
Mar 11 2019
CMS Seeks Comments on CLIA Proficiency Testing Regulations Related to Analytes and Acceptable Performance
Mar 08 2019
FDA Updates Safety Communication for Zoll LifeVest 4000 Wearable Cardioverter Defibrillator
Mar 07 2019
TJC Clarifies Use of Video Monitoring for Patients at High Risk for Suicide
Mar 07 2019
CMS Updates Surveyor Guidance on Immediate Jeopardy
Mar 06 2019
Class I Recall of RVO 2.0 Raindrop Near Vision Inlay
Mar 05 2019
CMS Memorandum Outlines Enhanced Oversight and Enforcement of Nursing Home Non-Improving Late Adopters
Mar 05 2019
Apotex Corp. Issues Voluntary Nationwide Recall of Drospirenone and Ethinyl Estradiol Tablets, USP
Mar 05 2019
CDC - Infection Prevention and Control Considerations for Ebola Virus Disease
Mar 04 2019
Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Losartan Potassium Tablets
Mar 01 2019
FDA Updates Investigation into ARB Drug Products
Mar 01 2019